Increased striatal expression of glutamate decarboxylase 67 after priming of 6-hydroxydopamine-lesioned rats

Neuroscience

Volumn 89, Issue 4, 1999, Pages 1183-1187

  Consolo, S ^a   Morelli, M ^b   Rimoldi, M ^a   Giorgi, S ^a   Di Chiara, G ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

6 Hydroxydopamine; Dopamine D1; GAD65; GAD67; Parkinson's disease; Sensitization

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; GLUTAMATE DECARBOXYLASE; LEVODOPA; OXIDOPAMINE;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CORPUS STRIATUM; DRUG EXPOSURE; GABAERGIC SYSTEM; GENE EXPRESSION; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSITIZATION;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; CORPUS STRIATUM; FUNCTIONAL LATERALITY; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTAMATE DECARBOXYLASE; ISOENZYMES; LEVODOPA; MALE; MOTOR ACTIVITY; NEURONS; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 0033049198     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00390-X     Document Type: Article

References (39)

1. Barone P., Morelli M., Popoli M., Cicarelli G., Campanella G., Di Chiara G. Behavioural sensitization in 6-hydroxydopamine lesioned rats involves the dopamine signal transduction: changes in DARPP-32 phosphorylation. Neuroscience. 61:1994;867-873.
2. Caboche J., Vernier P., Julien J.F., Rogard M., Mallet J., Besson M.J. Parallel decrease of glutamic acid decarboxylase and preproenkephalin mRNA in the rat striatum following chronic treatment with a dopaminergic D1 antagonist and agonist. J. Neurochem. 56:1991;428-435.
3. 2 receptors in the regulation of glutamic acid decaraboxylase messenger RNA in the striatum of the rat. Eur. J. Neurosci. 4:1992;428-435.
4. Chomczynsky P., Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Analyt. Biochem. 162:1987;156-159.
5. Engber T.M., Susel Z., Juncos J.L., Chase T.N. Continuous and intermittent levodopa differentially affect rotation induced by D-1 and D-2 dopamine agonists. Eur. J. Pharmac. 168:1989;291-298.
6. Engber T.M., Susel Z., Kuo S., Gerfen C.R., Chase T.N. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats. Brain Res. 552:1991;113-118.
7. Erlander M.G., Tillakaratne N.J., Feldblum S., Patel N., Tobin A.J. Two genes encode distinct glutamate decarboxylases. Neuron. 7:1991;91-100.
8. Esclapez M., Tillakaratne N.J. K., Kaufman D.L., Tobin A.J., Houser C.R. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J. Neurosci. 14:1994;1834-1855.
9. Feldblum S., Erlander M.G., Tobin A.J. Different distribution of GAD65 and GAD67 mRNAs suggest that the two glutamate decarboxylases play distinctive functional roles. J. Neurosci. Res. 34:1993;689-706.
10. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
11. Kaufman D.L., Houser C.R., Tobin A.J. Two forms of the γ-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J. Neurochem. 56:1991;720-723.
12. Laprade N., Soghomonian J.J. Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum. Molec. Brain Res. 34:1995;65-74.
13. Laprade N., Soghomonian J.-J. Glutamate decarboxylase (GAD65) gene expression is increased by dopamine receptor agonists in a subpopulation of rat striatal neurons. Molec. Brain Res. 48:1997;333-345.
14. 67 mRNA. Eur. J. Neurosci. 7:1995;1199-1209.
15. Lindefors N. Dopaminergic regulation of glutamic acid decarboxylase mRNA expression and GABA release in the striatum: a review. Prog. Neuropsychopharmac. biol. Psychiat. 17:1993;887-903.
16. Lindefors N., Brene S., Herrera-Marschitz M., Persson H. Region specific regulation of glutamic acid decarboxylase mRNA expression by dopamine neurons in rat brain. Expl Brain Res. 77:1989;611-620.
17. Litwak J., Mercugliano M., Chesselet M.F., Oltmans G.A. Increased glutamic acid decarboxylase (GAD) mRNA and GAD activity in cerebellar Purkinje cells following lesion-induced increases in cell firing. Neurosci. Lett. 116:1990;179-183.
18. Masseroli M., Messori A., Bendotti C., Forloni G.L. Automatic quantitative evaluation of autoradiographic band films computerized image analysis. Life Sci. 53:1993;331-336.
19. Martin D.L., Rimvall K. Regulation of γ-aminobutyric acid synthesis in the brain. J. Neurochem. 60:1993;395-407.
20. Mercugliano M., Soghomonian J.J., Qin Y., Nguyen H.Q., Feldblum S., Erlander M.G., Tobin A.J., Chesselet M.F. Comparative distribution of messenger RNAs encoding glutamic acid decarboxylases (Mr 65,000 and Mr 67,000) in the basal ganglia of the rat. J. comp. Neurol. 318:1992;245-254.
21. 1 receptor-adenylate cyclase complex after priming. Eur. J. Pharmac. 180:1990;365-367.
22. Morelli M., Di Chiara G. Agonist-induced homologous and heterologous sensitization to D-1 and D-2-dependent contraversive turning. Eur. J. Pharmac. 141:1987;101-107.
23. Morelli M., Fenu S., Di Chiara G. Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors. Life Sci. 40:1987;245-251.
24. Morelli M., Fenu S., Pinna A., Cozzolino A., Carta A., Di Chiara G. "Priming" to dopamine agonist-induced contralateral turning as a model of non-associative sensitization to the expression of the post-synaptic dopamine message. Behav. Pharmac. 4:1993;389-397.
25. 1 receptor stimulation in 6-OHDA lesioned rats: effect of sensitization (Priming) with a dopaminergic agonist. Synapse. 13:1993;264-269.
26. Pedneault S., Soghomonian J.-J. Glutamate decarboxylase (GAD65) mRNA levels in the striatum and pallidum of MPTP-treated monkeys. Molec. Brain Res. 25:1994;351-354.
27. Pellegrino L. J., Pellegrino A. S. and Cushman A. J. (1979) A Stereotaxic Atlas of the Rat Brain. Plenum, New York.
28. 1 receptor-dependent cyclic AMP production in striatal tissue. Eur. J. Pharmac. 331:1997;23-26.
29. Qin Z.H., Zhang S.P., Weiss B. Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain. Molec. Brain Res. 21:1994;293-302.
30. Segovia J., Tillakaratne N.J., Whelan K., Tobin A.J., Gale K. Parallel increases in striatal glutamic acid decarbaoxylase activity and mRNA levels in rats with lesions of the nigrostriatal pathway. Brain Res. 529:1990;345-348.
31. Soghomonian J.-J., Chesselet M.-F. Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat. Synapse. 11:1992;124-133.
32. Soghomonian J.-J., Gonzales C., Chesselet M.-F. Messenger RNAs encoding glutamate-decarboxylases are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons. Brain Res. 576:1992;68-74.
33. Soghomonian J.-J., Laprade N. Glutamate decarboxylase (GAD67 and GAD65) gene expression is increased in a subpopulation of neurons in the putamen of parkinsonian monkeys. Synapse. 27:1997;122-132.
34. Soghomonian J.-J., Pedneault S., Audet G., Parent A. Increased glutamate decarboxylase mRNA levels in the striatum and pallidum of MPTP-treated primates. J. Neurosci. 14:1994;6256-6265.
35. Soghomonian J.-J., Pedneault S., Blanchet P.J., Goulet M., Di Paolo T., Bédard P.J. L-DOPA regulates glutamate decarboxylases mRNA levels in MPTP-treated monkeys. Molec. Brain Res. 39:1996;237-240.
36. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta physiol. scand. 367:1971;69-93.
37. Vernier P., Julien J.F., Rataboul P., Fourrier O., Feuerstein C., Mallet J. Similar time course changes in striatal levels of glutamic acid decarboxylase and proenkephalin mRNA following dopaminergic deafferentation in the rat. J. Neurochem. 51:1988;1375-1380.
38. Wood T.L., Frantz G., Menkes J.H., Tobin A.J. Regional distribution of messenger RNAs in post-mortem human brain. J. Neurosci. Res. 16:1986;311-324.
39. Zeng B.-Y., Jolkkonen J., Jenner P., Marsden C.D. Chronic L-DOPA treatment differentially regulates gene expression of glutamate decarboxylase, preproenkephalin and preprotachykinin in the striatum of 6-hydroxydopamine-lesioned rat. Neuroscience. 66:1995;19-28.